Rocuronium Bromide Injection — FDA Drug Shortage

Current — Meitheal Pharmaceuticals, Inc.

The FDA lists a drug shortage record for Rocuronium Bromide Injection (injection) from Meitheal Pharmaceuticals, Inc. with status Current. The shortage was first posted on Feb 15, 2023.

Shortage details

Status
Current
Company
Meitheal Pharmaceuticals, Inc.
Package NDC
71288-718-11
Dosage Form
Injection
Presentation
Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 71288-718-11)
Initial Posting
Feb 15, 2023

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.